Yasuaki Anami

1.6k total citations · 2 hit papers
22 papers, 1.0k citations indexed

About

Yasuaki Anami is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Yasuaki Anami has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Yasuaki Anami's work include HER2/EGFR in Cancer Research (12 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Vitamin D Research Studies (7 papers). Yasuaki Anami is often cited by papers focused on HER2/EGFR in Cancer Research (12 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Vitamin D Research Studies (7 papers). Yasuaki Anami collaborates with scholars based in United States, Japan and India. Yasuaki Anami's co-authors include Kyoji Tsuchikama, Chisato M. Yamazaki, Summer Y.Y. Ha, Ningyan Zhang, Zhiqiang An, Wei Xiong, Xun Gui, Aiko Yamaguchi, Jangsoon Lee and Naoto T. Ueno and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Cancer Research.

In The Last Decade

Yasuaki Anami

22 papers receiving 1000 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exploring the next generation of antibody–drug conjugates

2024 276 citations Kyoji Tsuchikama, Yasuaki Anami et al. Nature Reviews Clinical Oncology profile →
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance

2021 210 citations Chisato M. Yamazaki, Aiko Yamaguchi et al. Nature Communications profile →

Peers

Yasuaki Anami

ONCOL

RNMI

IMMUN

Sharon Wilhelm United States

Arris J. Henderson United States

Peter Bross United States

Christel Vangestel Belgium

Sara Kenkare-Mitra United States

Marika Nestor Sweden

Sai Kiran Sharma United States

Kelly M. Flagella United States

Kedan Lin United States

Julia Kirshner United States

Sharon Wilhelm United States

Yasuaki Anami

859 ×1.5

ONCOL

802 ×1.7

RNMI

398 ×1.1

192 ×1.5

104 ×1.2

IMMUN

Citations per year, relative to Yasuaki Anami Yasuaki Anami (= 1×) peers Sharon Wilhelm

Countries citing papers authored by Yasuaki Anami

Since Specialization

Citations

This map shows the geographic impact of Yasuaki Anami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuaki Anami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuaki Anami more than expected).

Fields of papers citing papers by Yasuaki Anami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuaki Anami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuaki Anami. The network helps show where Yasuaki Anami may publish in the future.

Co-authorship network of co-authors of Yasuaki Anami

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuaki Anami. A scholar is included among the top collaborators of Yasuaki Anami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuaki Anami. Yasuaki Anami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamaguchi, Aiko, Chisato M. Yamazaki, Yasuaki Anami, et al.. (2025). 177Lu-Labeled Antibody–Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors. Molecular Cancer Therapeutics. 24(6). 907–919. 4 indexed citations

Tsuchikama, Kyoji, Yasuaki Anami, Summer Y.Y. Ha, & Chisato M. Yamazaki. (2024). Exploring the next generation of antibody–drug conjugates. Nature Reviews Clinical Oncology. 21(3). 203–223. 276 indexed citations breakdown →

Anami, Yasuaki, Zhengdong Liang, Sukhen C. Ghosh, et al.. (2024). Antibody–Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Antitumor Activity in Colorectal Cancer. Cancer Research. 85(5). 973–986. 5 indexed citations

Ha, Summer Y.Y., Yasuaki Anami, Chisato M. Yamazaki, et al.. (2022). An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 21(9). 1449–1461. 36 indexed citations

Anami, Yasuaki, Yoshihiro Otani, Wei Xiong, et al.. (2022). Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors. Cell Reports. 39(8). 110839–110839. 36 indexed citations

Zhao, Peng, Yasuaki Anami, Xuejun Fan, et al.. (2022). Enhanced anti-angiogenetic effect of transferrin receptor-mediated delivery of VEGF-trap in a glioblastoma mouse model. mAbs. 14(1). 2057269–2057269. 13 indexed citations

Yamaguchi, Aiko, Yasuaki Anami, Summer Y.Y. Ha, et al.. (2021). Chemical generation of small molecule-based bispecific antibody-drug conjugates for broadening the target scope. Bioorganic & Medicinal Chemistry. 32. 116013–116013. 16 indexed citations

Yamazaki, Chisato M., Aiko Yamaguchi, Yasuaki Anami, et al.. (2021). Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance. Nature Communications. 12(1). 3528–3528. 210 indexed citations breakdown →

Anami, Yasuaki & Kyoji Tsuchikama. (2020). Next-generation Antibody-drug Conjugates (ADCs): Exploring New Frontiers with Chemical Approaches. Journal of Synthetic Organic Chemistry Japan. 78(5). 503–515. 1 indexed citations

10.

Nicolaou, K. C., et al.. (2020). Total Synthesis of the Monomeric Unit of Lomaiviticin A. Journal of the American Chemical Society. 142(47). 20201–20207. 18 indexed citations

11.

Anami, Yasuaki, Mi Deng, Xun Gui, et al.. (2020). LILRB4-targeting Antibody–Drug Conjugates for the Treatment of Acute Myeloid Leukemia. Molecular Cancer Therapeutics. 19(11). 2330–2339. 42 indexed citations

12.

Anami, Yasuaki, Chisato M. Yamazaki, Wei Xiong, et al.. (2018). Glutamic acid–valine–citrulline linkers ensure stability and efficacy of antibody–drug conjugates in mice. Nature Communications. 9(1). 2512–2512. 161 indexed citations

13.

Itoh, Toshimasa, Tatsuya HORI, Akira Kato, et al.. (2018). Identification of the Histidine Residue in Vitamin D Receptor That Covalently Binds to Electrophilic Ligands. Journal of Medicinal Chemistry. 61(14). 6339–6349. 23 indexed citations

14.

Anami, Yasuaki, Wei Xiong, Xun Gui, et al.. (2017). Enzymatic conjugation using branched linkers for constructing homogeneous antibody–drug conjugates with high potency. Organic & Biomolecular Chemistry. 15(26). 5635–5642. 69 indexed citations

15.

Tsuchikama, Kyoji, et al.. (2017). Truncated Autoinducing Peptide Conjugates Selectively Recognize and Kill Staphylococcus aureus. ACS Infectious Diseases. 3(6). 406–410. 11 indexed citations

16.

Itoh, Toshimasa, et al.. (2016). SRC2-3 binds to vitamin D receptor with high sensitivity and strong affinity. Bioorganic & Medicinal Chemistry. 25(2). 568–574. 10 indexed citations

17.

Anami, Yasuaki, Nobutaka Shimizu, Toru Ekimoto, et al.. (2016). Apo- and Antagonist-Binding Structures of Vitamin D Receptor Ligand-Binding Domain Revealed by Hybrid Approach Combining Small-Angle X-ray Scattering and Molecular Dynamics. Journal of Medicinal Chemistry. 59(17). 7888–7900. 21 indexed citations

18.

Anami, Yasuaki, Toshimasa Itoh, Y. Inaba, et al.. (2015). Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity. Bioorganic & Medicinal Chemistry. 23(22). 7274–7281. 9 indexed citations

19.

Yamamoto, Keiko, Yasuaki Anami, & Toshimasa Itoh. (2014). Development of Vitamin D Analogs Modulating the Pocket Structure of Vitamin D Receptor. Current Topics in Medicinal Chemistry. 14(21). 2378–2387. 6 indexed citations

20.

Anami, Yasuaki, et al.. (2014). A Mixed Population of Antagonist and Agonist Binding Conformers in a Single Crystal Explains Partial Agonism against Vitamin D Receptor: Active Vitamin D Analogues with 22R-Alkyl Group. Journal of Medicinal Chemistry. 57(10). 4351–4367. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact